Trade Show News
Stay updated with the latest trade show news through detailed press releases. Learn about upcoming events, key highlights, and industry trends. Get insights into significant trade show announcements, exhibitor information, and post-event analyses.
Mar 30, 2026 at 11:38 AM
Resecurity Supported Phoenix Challenge® 2026 – Information Operations (IO) Excellence in Cyberspace
LOS ANGELES--(BUSINESS WIRE)--Resecurity, a global cybersecurity and threat-intelligence company trusted by Fortune 100 enterprises and government agencies, was honored to participate in Phoenix Challenge 2026, held March 23–25, 2026, at the Crystal Gateway Marriott in Arlington, Virginia. Phoenix Challenge® is a U.S. Department of War conference focused on promoting innovation and advancing information operations (IO). The conference is presented under the oversight of the Office of Informatio...
Mar 30, 2026 at 10:00 AM
Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
NEW ORLEANS--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced new data on the EVOQUE transcatheter tricuspid valve replacement (TTVR) system at the American College of Cardiology Annual Scientific Session (ACC.26), demonstrating significant and sustained patient benefits including lower mortality when accounting for patient crossover, extending the findings presented at the European Society of Cardiology Congress (ESC 2025). The new TRISCEND II trial data presented today during...
Mar 30, 2026 at 9:15 AM
Docebo Announces Participation in Upcoming Investor Conferences in April and May
TORONTO--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO, TSX: DCBO), a leading AI workforce readiness platform that connects skills intelligence, learning execution, and measurable outcomes, announced today that members of its management team will present at the following investor and software industry conferences in April and May 2026: April: Docebo Inspire - Investor Briefing - April 21st - Miami May: 21st Annual Needham Technology, Media, & Consumer Conference - May 12th - New York CIBC Tech...
Mar 30, 2026 at 8:00 AM
SentiLink Named a 2026 FICO Industry Vanguard Decision Award Winner for Leadership in Identity Theft Detection
BOZEMAN, Mont.--(BUSINESS WIRE)--FICO has named SentiLink a 2026 FICO® Industry Vanguard Decision Award winner....
Mar 30, 2026 at 6:55 AM
Magnachip Launches 8th-Generation 40V and 60V MV MOSFETs for Servers and High-Performance PCs
SEOUL, South Korea--(BUSINESS WIRE)--Magnachip Semiconductor Corporation (NYSE: MX, “Magnachip”) today announced the launch of its new 8th-generation 40V and 60V Medium-Voltage (MV) MOSFETs, designed for server and high-performance PC power supply units. As power demand in the global server and data center market increases, power efficiency and power density have emerged as important factors for power semiconductor solutions used in servers and data center applications. With these new 8th-gener...
Mar 30, 2026 at 2:00 AM
AltynGold Plc ("AltynGold" or the "Company") Participation in MINEX Kazakhstan 2026
LONDON--(BUSINESS WIRE)--AltynGold (LSE:ALTN), the Kazakh metals, mining and energy group, is pleased to announce its participation as an exhibitor at the MINEX Kazakhstan Mining & Exploration Forum 2026, taking place 14–16 April 2026 in Astana, Kazakhstan. MINEX Kazakhstan is one of the region’s leading mining and exploration forums, bringing together government representatives, mining companies, investors and industry stakeholders to discuss developments across Central Asia’s mining secto...
Mar 29, 2026 at 11:45 AM
Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for WINREVAIR™ (sotatercept-csrk) in Adults With the Syndrome of Combined Post- and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
RAHWAY, N.J.--(BUSINESS WIRE)--Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for Merck’s WINREVAIR in Adults With CpcPH-HFpEF...
Mar 28, 2026 at 7:00 AM
Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy™ (xanomeline and trospium chloride)
PRINCETON, N.J.--(BUSINESS WIRE)--Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy....
Mar 27, 2026 at 10:00 AM
Mountain Mike’s Pizza Wins FRANdata 2026 TopScore FUND Award
IRVINE, Calif.--(BUSINESS WIRE)--Mountain Mike’s Pizza has been named the 2026 TopScore FUND Award winner in the Food category by FRANdata....
Mar 27, 2026 at 9:00 AM
Lebrikizumab delivered long-term disease control for up to four years in patients with moderate-to-severe atopic dermatitis
BARCELONA, Spain--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today presented positive long-term interim results from the ongoing Phase 3b ADlong study evaluating the efficacy and safety of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis (AD). Lebrikizumab delivered near-complete skin clearance and itch relief for up to four years for patients with moderate-to-severe atopic dermatitis, while maintaini...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.